All clinical trials have only used the Patented Microencapsulated BioResponse DIM Formulation, including clinical trials sponsored by the National Cancer Institute.
Clinical trials are currently underway using BioResponse DIM in collaboration with University of Arizona, Wayne State University, and Women's College Research Institute. BR-DIM has been written up in the American Journal of Translational Research. BioResponse Nutrients works with the National Cancer Institute (NCI) under a clinical trials agreement to discover the further health potential of DIM.
Explore Current and Completed Clinical Trials Research:
Search "BioResponse DIM" on ClinicalTrials.gov